Pharmacovigilance (PV) Outsourcing Market Report

Global and Regional Pharmacovigilance (PV) Outsourcing Market Details Research Report 2021-2026

  • POSTDATE：Jun 24, 2021
  • PAGES：198
  • REPORT CODE：GMM712453
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Pharmacovigilance (PV) Outsourcing Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Pharmacovigilance (PV) Outsourcing market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Pharmacovigilance (PV) Outsourcing market.

    By Player:

    • Ergomed

    • Symogen

    • Parexel

    • PharmInvent

    • Deloitte Touche Tohmatsu Limited

    • Sciformix

    • iGATE Corporation

    • Medpace Holdings

    • IQVIA

    • Oracle Corporation

    • PrimeVigilance

    • Covance

    • C3i Solutions

    • ELC Group

    • Accenture

    • Novartis

    • Clintec

    • Pure Drug Safety

    • SIRO Clinpharm

    • iMED Global Corporation

    • MarksMan Healthcare

    By Type:

    • Contract Research Organizations (CROs)

    • Business Process Outsourcing (BPOs)

    By End-User:

    • Premarketing Clinical Trial

    • Post-marketing Clinical Practice

    • Other

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Pharmacovigilance (PV) Outsourcing Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Pharmacovigilance (PV) Outsourcing Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Pharmacovigilance (PV) Outsourcing Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Pharmacovigilance (PV) Outsourcing Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Pharmacovigilance (PV) Outsourcing Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Pharmacovigilance (PV) Outsourcing Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Ergomed

      • 3.1.1 Ergomed - Company Business Overview

      • 3.1.2 Ergomed - Company Financial Performance

      • 3.1.3 Ergomed - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.1.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 Symogen

      • 3.2.1 Symogen - Company Business Overview

      • 3.2.2 Symogen - Company Financial Performance

      • 3.2.3 Symogen - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.2.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 Parexel

      • 3.3.1 Parexel - Company Business Overview

      • 3.3.2 Parexel - Company Financial Performance

      • 3.3.3 Parexel - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.3.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 PharmInvent

      • 3.4.1 PharmInvent - Company Business Overview

      • 3.4.2 PharmInvent - Company Financial Performance

      • 3.4.3 PharmInvent - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.4.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 Deloitte Touche Tohmatsu Limited

      • 3.5.1 Deloitte Touche Tohmatsu Limited - Company Business Overview

      • 3.5.2 Deloitte Touche Tohmatsu Limited - Company Financial Performance

      • 3.5.3 Deloitte Touche Tohmatsu Limited - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.5.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 Sciformix

      • 3.6.1 Sciformix - Company Business Overview

      • 3.6.2 Sciformix - Company Financial Performance

      • 3.6.3 Sciformix - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.6.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 iGATE Corporation

      • 3.7.1 iGATE Corporation - Company Business Overview

      • 3.7.2 iGATE Corporation - Company Financial Performance

      • 3.7.3 iGATE Corporation - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.7.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 Medpace Holdings

      • 3.8.1 Medpace Holdings - Company Business Overview

      • 3.8.2 Medpace Holdings - Company Financial Performance

      • 3.8.3 Medpace Holdings - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.8.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 IQVIA

      • 3.9.1 IQVIA - Company Business Overview

      • 3.9.2 IQVIA - Company Financial Performance

      • 3.9.3 IQVIA - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.9.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 Oracle Corporation

      • 3.10.1 Oracle Corporation - Company Business Overview

      • 3.10.2 Oracle Corporation - Company Financial Performance

      • 3.10.3 Oracle Corporation - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.10.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.10.5 Strategic Initiatives

    • 3.11 PrimeVigilance

      • 3.11.1 PrimeVigilance - Company Business Overview

      • 3.11.2 PrimeVigilance - Company Financial Performance

      • 3.11.3 PrimeVigilance - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.11.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.11.5 Strategic Initiatives

    • 3.12 Covance

      • 3.12.1 Covance - Company Business Overview

      • 3.12.2 Covance - Company Financial Performance

      • 3.12.3 Covance - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.12.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.12.5 Strategic Initiatives

    • 3.13 C3i Solutions

      • 3.13.1 C3i Solutions - Company Business Overview

      • 3.13.2 C3i Solutions - Company Financial Performance

      • 3.13.3 C3i Solutions - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.13.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.13.5 Strategic Initiatives

    • 3.14 ELC Group

      • 3.14.1 ELC Group - Company Business Overview

      • 3.14.2 ELC Group - Company Financial Performance

      • 3.14.3 ELC Group - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.14.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.14.5 Strategic Initiatives

    • 3.15 Accenture

      • 3.15.1 Accenture - Company Business Overview

      • 3.15.2 Accenture - Company Financial Performance

      • 3.15.3 Accenture - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.15.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.15.5 Strategic Initiatives

    • 3.16 Novartis

      • 3.16.1 Novartis - Company Business Overview

      • 3.16.2 Novartis - Company Financial Performance

      • 3.16.3 Novartis - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.16.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.16.5 Strategic Initiatives

    • 3.17 Clintec

      • 3.17.1 Clintec - Company Business Overview

      • 3.17.2 Clintec - Company Financial Performance

      • 3.17.3 Clintec - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.17.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.17.5 Strategic Initiatives

    • 3.18 Pure Drug Safety

      • 3.18.1 Pure Drug Safety - Company Business Overview

      • 3.18.2 Pure Drug Safety - Company Financial Performance

      • 3.18.3 Pure Drug Safety - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.18.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.18.5 Strategic Initiatives

    • 3.19 SIRO Clinpharm

      • 3.19.1 SIRO Clinpharm - Company Business Overview

      • 3.19.2 SIRO Clinpharm - Company Financial Performance

      • 3.19.3 SIRO Clinpharm - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.19.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.19.5 Strategic Initiatives

    • 3.20 iMED Global Corporation

      • 3.20.1 iMED Global Corporation - Company Business Overview

      • 3.20.2 iMED Global Corporation - Company Financial Performance

      • 3.20.3 iMED Global Corporation - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.20.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.20.5 Strategic Initiatives

    • 3.21 MarksMan Healthcare

      • 3.21.1 MarksMan Healthcare - Company Business Overview

      • 3.21.2 MarksMan Healthcare - Company Financial Performance

      • 3.21.3 MarksMan Healthcare - Company Financial Performance of Pharmacovigilance (PV) Outsourcing

      • 3.21.4 Pharmacovigilance (PV) Outsourcing Product Benchmarking

      • 3.21.5 Strategic Initiatives

    4 Global Pharmacovigilance (PV) Outsourcing Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Pharmacovigilance (PV) Outsourcing Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of Contract Research Organizations (CROs) 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of Business Process Outsourcing (BPOs) 2016-2021

    • 4.3 Global Pharmacovigilance (PV) Outsourcing Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of Contract Research Organizations (CROs) 2016-2021

      • 4.3.2 Global Sales and Growth Rate of Business Process Outsourcing (BPOs) 2016-2021

    • 4.4 Global Pharmacovigilance (PV) Outsourcing Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Pharmacovigilance (PV) Outsourcing Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Pharmacovigilance (PV) Outsourcing Market Price By Type from 2016 to 2026

    5 Global Pharmacovigilance (PV) Outsourcing Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Pharmacovigilance (PV) Outsourcing

    • 5.2 Global Pharmacovigilance (PV) Outsourcing Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Premarketing Clinical Trial 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Post-marketing Clinical Practice 2016-2021

      • 5.2.3 Global Revenue and Growth Rate of Other 2016-2021

    • 5.3 Global Pharmacovigilance (PV) Outsourcing Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Premarketing Clinical Trial 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Post-marketing Clinical Practice 2016-2021

      • 5.3.3 Global Sales and Growth Rate of Other 2016-2021

    • 5.4 Global Pharmacovigilance (PV) Outsourcing Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Pharmacovigilance (PV) Outsourcing Market Sales and Market Share by Application (Forecast)

    6 Global Pharmacovigilance (PV) Outsourcing Market Segment Analysis (Geography Level)

    • 6.1 Global Pharmacovigilance (PV) Outsourcing Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Pharmacovigilance (PV) Outsourcing Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Pharmacovigilance (PV) Outsourcing Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Pharmacovigilance (PV) Outsourcing Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Pharmacovigilance (PV) Outsourcing Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Pharmacovigilance (PV) Outsourcing Market from 2016 to 2020

    7. North America Pharmacovigilance (PV) Outsourcing Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Pharmacovigilance (PV) Outsourcing Market Segment by Countries

      • 7.1.1 North America Pharmacovigilance (PV) Outsourcing Market Revenue Segment by Countries

      • 7.1.2 North America Pharmacovigilance (PV) Outsourcing Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Pharmacovigilance (PV) Outsourcing Market Segment (Product Type Level)

    • 7.3 North America Pharmacovigilance (PV) Outsourcing Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Pharmacovigilance (PV) Outsourcing Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Pharmacovigilance (PV) Outsourcing Market Segment by Countries

      • 8.1.1 Europe Pharmacovigilance (PV) Outsourcing Market Revenue Segment by Countries

      • 8.1.2 Europe Pharmacovigilance (PV) Outsourcing Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Pharmacovigilance (PV) Outsourcing Market Segment (Product Type Level)

    • 8.3 Europe Pharmacovigilance (PV) Outsourcing Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Pharmacovigilance (PV) Outsourcing Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Pharmacovigilance (PV) Outsourcing Market Segment by Countries

      • 9.1.1 Asia Pharmacovigilance (PV) Outsourcing Market Revenue Segment by Countries

      • 9.1.2 Asia Pharmacovigilance (PV) Outsourcing Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Pharmacovigilance (PV) Outsourcing Market Segment (Product Type Level)

    • 9.3 Asia Pharmacovigilance (PV) Outsourcing Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Pharmacovigilance (PV) Outsourcing Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Pharmacovigilance (PV) Outsourcing Market Segment by Countries

      • 10.1.1 South America Pharmacovigilance (PV) Outsourcing Market Revenue Segment by Countries

      • 10.1.2 South America Pharmacovigilance (PV) Outsourcing Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Pharmacovigilance (PV) Outsourcing Market Segment (Product Type Level)

    • 10.3 South America Pharmacovigilance (PV) Outsourcing Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Pharmacovigilance (PV) Outsourcing Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Pharmacovigilance (PV) Outsourcing Market Segment by Countries

      • 11.1.1 Middle East Pharmacovigilance (PV) Outsourcing Market Revenue Segment by Countries

      • 11.1.2 Middle East Pharmacovigilance (PV) Outsourcing Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Pharmacovigilance (PV) Outsourcing Market Segment (Product Type Level)

    • 11.3 Middle East Pharmacovigilance (PV) Outsourcing Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Pharmacovigilance (PV) Outsourcing Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Pharmacovigilance (PV) Outsourcing Market Segment by Countries

      • 12.1.1 Africa Pharmacovigilance (PV) Outsourcing Market Revenue Segment by Countries

      • 12.1.2 Africa Pharmacovigilance (PV) Outsourcing Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Pharmacovigilance (PV) Outsourcing Market Segment (Product Type Level)

    • 12.3 Africa Pharmacovigilance (PV) Outsourcing Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Pharmacovigilance (PV) Outsourcing Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Pharmacovigilance (PV) Outsourcing Market Segment by Countries

      • 13.1.1 Oceania Pharmacovigilance (PV) Outsourcing Market Revenue Segment by Countries

      • 13.1.2 Oceania Pharmacovigilance (PV) Outsourcing Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Pharmacovigilance (PV) Outsourcing Market Segment (Product Type Level)

    • 13.3 Oceania Pharmacovigilance (PV) Outsourcing Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Pharmacovigilance (PV) Outsourcing Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Pharmacovigilance (PV) Outsourcing

      • 14.2.2 Manufacturing Process Analysis of Pharmacovigilance (PV) Outsourcing

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Pharmacovigilance (PV) Outsourcing Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Pharmacovigilance (PV) Outsourcing Industry Market Status, Pre-COVID-19

      • 15.5.3 Pharmacovigilance (PV) Outsourcing Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Pharmacovigilance (PV) Outsourcing Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Pharmacovigilance (PV) Outsourcing Product Picture

    • Table Pharmacovigilance (PV) Outsourcing Product Definition

    • Table Study Scope by Types

    • Figure Global Pharmacovigilance (PV) Outsourcing Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Pharmacovigilance (PV) Outsourcing Market Value by Application (2016 - 2026)

    • Figure Global Pharmacovigilance (PV) Outsourcing Market Size and Growth Rate from 2016 to 2026

    • Table Global Pharmacovigilance (PV) Outsourcing Production Capacity by Manufacturers (2016-2021)

    • Table Global Pharmacovigilance (PV) Outsourcing Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Pharmacovigilance (PV) Outsourcing Revenue by Manufacturers (2016-2021)

    • Table Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Pharmacovigilance (PV) Outsourcing Plant Distribution and Sales Country

    • Table Ergomed - Company Business Overview

    • Figure Ergomed Total Revenue from 2018 to 2020

    • Table Ergomed Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Ergomed Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of Ergomed

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table Symogen - Company Business Overview

    • Figure Symogen Total Revenue from 2018 to 2020

    • Table Symogen Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Symogen Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of Symogen

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table Parexel - Company Business Overview

    • Figure Parexel Total Revenue from 2018 to 2020

    • Table Parexel Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Parexel Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of Parexel

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table PharmInvent - Company Business Overview

    • Figure PharmInvent Total Revenue from 2018 to 2020

    • Table PharmInvent Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure PharmInvent Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of PharmInvent

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table Deloitte Touche Tohmatsu Limited - Company Business Overview

    • Figure Deloitte Touche Tohmatsu Limited Total Revenue from 2018 to 2020

    • Table Deloitte Touche Tohmatsu Limited Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Deloitte Touche Tohmatsu Limited Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of Deloitte Touche Tohmatsu Limited

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table Sciformix - Company Business Overview

    • Figure Sciformix Total Revenue from 2018 to 2020

    • Table Sciformix Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Sciformix Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of Sciformix

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table iGATE Corporation - Company Business Overview

    • Figure iGATE Corporation Total Revenue from 2018 to 2020

    • Table iGATE Corporation Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure iGATE Corporation Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of iGATE Corporation

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table Medpace Holdings - Company Business Overview

    • Figure Medpace Holdings Total Revenue from 2018 to 2020

    • Table Medpace Holdings Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Medpace Holdings Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of Medpace Holdings

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table IQVIA - Company Business Overview

    • Figure IQVIA Total Revenue from 2018 to 2020

    • Table IQVIA Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure IQVIA Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of IQVIA

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table Oracle Corporation - Company Business Overview

    • Figure Oracle Corporation Total Revenue from 2018 to 2020

    • Table Oracle Corporation Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Oracle Corporation Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of Oracle Corporation

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table PrimeVigilance - Company Business Overview

    • Figure PrimeVigilance Total Revenue from 2018 to 2020

    • Table PrimeVigilance Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure PrimeVigilance Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of PrimeVigilance

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table Covance - Company Business Overview

    • Figure Covance Total Revenue from 2018 to 2020

    • Table Covance Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Covance Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of Covance

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table C3i Solutions - Company Business Overview

    • Figure C3i Solutions Total Revenue from 2018 to 2020

    • Table C3i Solutions Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure C3i Solutions Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of C3i Solutions

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table ELC Group - Company Business Overview

    • Figure ELC Group Total Revenue from 2018 to 2020

    • Table ELC Group Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure ELC Group Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of ELC Group

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table Accenture - Company Business Overview

    • Figure Accenture Total Revenue from 2018 to 2020

    • Table Accenture Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Accenture Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of Accenture

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table Novartis - Company Business Overview

    • Figure Novartis Total Revenue from 2018 to 2020

    • Table Novartis Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Novartis Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table Clintec - Company Business Overview

    • Figure Clintec Total Revenue from 2018 to 2020

    • Table Clintec Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Clintec Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of Clintec

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table Pure Drug Safety - Company Business Overview

    • Figure Pure Drug Safety Total Revenue from 2018 to 2020

    • Table Pure Drug Safety Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Pure Drug Safety Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of Pure Drug Safety

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table SIRO Clinpharm - Company Business Overview

    • Figure SIRO Clinpharm Total Revenue from 2018 to 2020

    • Table SIRO Clinpharm Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure SIRO Clinpharm Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of SIRO Clinpharm

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table iMED Global Corporation - Company Business Overview

    • Figure iMED Global Corporation Total Revenue from 2018 to 2020

    • Table iMED Global Corporation Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure iMED Global Corporation Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of iMED Global Corporation

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table MarksMan Healthcare - Company Business Overview

    • Figure MarksMan Healthcare Total Revenue from 2018 to 2020

    • Table MarksMan Healthcare Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure MarksMan Healthcare Sales and Growth Rate Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Revenue and Market Share Analysis of MarksMan Healthcare

    • Table Pharmacovigilance (PV) Outsourcing Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Pharmacovigilance (PV) Outsourcing Market Revenue by Types (Historical)

    • Table Global Pharmacovigilance (PV) Outsourcing Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of Contract Research Organizations (CROs) 2016-2021

    • Figure Global Revenue and Growth Rate of Business Process Outsourcing (BPOs) 2016-2021

    • Table Global Pharmacovigilance (PV) Outsourcing Market Sales by Types (Historical)

    • Table Global Pharmacovigilance (PV) Outsourcing Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of Contract Research Organizations (CROs) 2016-2021

    • Figure Global Sales and Growth Rate of Business Process Outsourcing (BPOs) 2016-2021

    • Table Global Pharmacovigilance (PV) Outsourcing Market Revenue by Types (Forecast)

    • Table Global Pharmacovigilance (PV) Outsourcing Market Revenue Market Share by Types (Forecast)

    • Table Global Pharmacovigilance (PV) Outsourcing Market Sales by Types (Forecast)

    • Table Global Pharmacovigilance (PV) Outsourcing Market Sales Market Share by Types (Forecast)

    • Figure Global Pharmacovigilance (PV) Outsourcing Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Pharmacovigilance (PV) Outsourcing

    • Table Global Pharmacovigilance (PV) Outsourcing Market Revenue by Application (Historical)

    • Table Global Pharmacovigilance (PV) Outsourcing Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Premarketing Clinical Trial 2016-2021

    • Figure Global Revenue and Growth Rate of Post-marketing Clinical Practice 2016-2021

    • Figure Global Revenue and Growth Rate of Other 2016-2021

    • Table Global Pharmacovigilance (PV) Outsourcing Market Sales by Application (Historical)

    • Table Global Pharmacovigilance (PV) Outsourcing Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Premarketing Clinical Trial 2016-2021

    • Figure Global Sales and Growth Rate of Post-marketing Clinical Practice 2016-2021

    • Figure Global Sales and Growth Rate of Other 2016-2021

    • Table Global Pharmacovigilance (PV) Outsourcing Market Revenue by Application (Forecast)

    • Table Global Pharmacovigilance (PV) Outsourcing Market Revenue Market Share by Application (Forecast)

    • Table Global Pharmacovigilance (PV) Outsourcing Market Sales by Application (Forecast)

    • Table Global Pharmacovigilance (PV) Outsourcing Market Sales Market Share by Application (Forecast)

    • Table Global Pharmacovigilance (PV) Outsourcing Market Revenue by Geography (Historical)

    • Table Global Pharmacovigilance (PV) Outsourcing Market Revenue Market Share by Geography (Historical)

    • Figure Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Geography in 2020

    • Table Global Pharmacovigilance (PV) Outsourcing Market Sales by Geography (Historical)

    • Table Global Pharmacovigilance (PV) Outsourcing Market Sales Market Share by Geography (Historical)

    • Figure Global Pharmacovigilance (PV) Outsourcing Sales Market Share by Geography in 2020

    • Table Global Pharmacovigilance (PV) Outsourcing Market Revenue by Geography (Forecast)

    • Table Global Pharmacovigilance (PV) Outsourcing Market Revenue Market Share by Geography (Forecast)

    • Table Global Pharmacovigilance (PV) Outsourcing Market Sales by Geography (Forecast)

    • Table Global Pharmacovigilance (PV) Outsourcing Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Pharmacovigilance (PV) Outsourcing Revenue by Countries from 2016 to 2026

    • Table North America Pharmacovigilance (PV) Outsourcing Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Pharmacovigilance (PV) Outsourcing Revenue Market Share by Major Countries in 2020

    • Table North America Pharmacovigilance (PV) Outsourcing Sales by Countries from 2016 to 2026

    • Table North America Pharmacovigilance (PV) Outsourcing Sales Market Share by Countries from 2016 to 2026

    • Figure North America Pharmacovigilance (PV) Outsourcing Sales Market Share by Major Countries in 2020

    • Figure USA Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure USA Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Table North America Pharmacovigilance (PV) Outsourcing Sales by Types from 2016 to 2026

    • Table North America Pharmacovigilance (PV) Outsourcing Sales Market Share by Types from 2016 to 2026

    • Table North America Pharmacovigilance (PV) Outsourcing Value by Types from 2016 to 2026

    • Table North America Pharmacovigilance (PV) Outsourcing Value Market Share by Types from 2016 to 2026

    • Table North America Pharmacovigilance (PV) Outsourcing Sales by Application from 2016 to 2026

    • Table North America Pharmacovigilance (PV) Outsourcing Sales Market Share by Application from 2016 to 2026

    • Table North America Pharmacovigilance (PV) Outsourcing Value by Application from 2016 to 2026

    • Table North America Pharmacovigilance (PV) Outsourcing Value Market Share by Application from 2016 to 2026

    • Table Europe Pharmacovigilance (PV) Outsourcing Revenue by Countries from 2016 to 2026

    • Table Europe Pharmacovigilance (PV) Outsourcing Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Pharmacovigilance (PV) Outsourcing Revenue Market Share by Major Countries in 2020

    • Table Europe Pharmacovigilance (PV) Outsourcing Sales by Countries from 2016 to 2026

    • Table Europe Pharmacovigilance (PV) Outsourcing Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Pharmacovigilance (PV) Outsourcing Sales Market Share by Major Countries in 2020

    • Figure Germany Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure France Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure France Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Pharmacovigilance (PV) Outsourcing Sales by Types from 2016 to 2026

    • Table Europe Pharmacovigilance (PV) Outsourcing Sales Market Share by Types from 2016 to 2026

    • Table Europe Pharmacovigilance (PV) Outsourcing Value by Types from 2016 to 2026

    • Table Europe Pharmacovigilance (PV) Outsourcing Value Market Share by Types from 2016 to 2026

    • Table Europe Pharmacovigilance (PV) Outsourcing Sales by Application from 2016 to 2026

    • Table Europe Pharmacovigilance (PV) Outsourcing Sales Market Share by Application from 2016 to 2026

    • Table Europe Pharmacovigilance (PV) Outsourcing Value by Application from 2016 to 2026

    • Table Europe Pharmacovigilance (PV) Outsourcing Value Market Share by Application from 2016 to 2026

    • Table Asia Pharmacovigilance (PV) Outsourcing Revenue by Countries from 2016 to 2026

    • Table Asia Pharmacovigilance (PV) Outsourcing Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Pharmacovigilance (PV) Outsourcing Revenue Market Share by Major Countries in 2020

    • Table Asia Pharmacovigilance (PV) Outsourcing Sales by Countries from 2016 to 2026

    • Table Asia Pharmacovigilance (PV) Outsourcing Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Pharmacovigilance (PV) Outsourcing Sales Market Share by Major Countries in 2020

    • Figure China Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure China Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure India Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure India Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Pharmacovigilance (PV) Outsourcing Sales by Types from 2016 to 2026

    • Table Asia Pharmacovigilance (PV) Outsourcing Sales Market Share by Types from 2016 to 2026

    • Table Asia Pharmacovigilance (PV) Outsourcing Value by Types from 2016 to 2026

    • Table Asia Pharmacovigilance (PV) Outsourcing Value Market Share by Types from 2016 to 2026

    • Table Asia Pharmacovigilance (PV) Outsourcing Sales by Application from 2016 to 2026

    • Table Asia Pharmacovigilance (PV) Outsourcing Sales Market Share by Application from 2016 to 2026

    • Table Asia Pharmacovigilance (PV) Outsourcing Value by Application from 2016 to 2026

    • Table Asia Pharmacovigilance (PV) Outsourcing Value Market Share by Application from 2016 to 2026

    • Table South America Pharmacovigilance (PV) Outsourcing Revenue by Countries from 2016 to 2026

    • Table South America Pharmacovigilance (PV) Outsourcing Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Pharmacovigilance (PV) Outsourcing Revenue Market Share by Major Countries in 2020

    • Table South America Pharmacovigilance (PV) Outsourcing Sales by Countries from 2016 to 2026

    • Table South America Pharmacovigilance (PV) Outsourcing Sales Market Share by Countries from 2016 to 2026

    • Figure South America Pharmacovigilance (PV) Outsourcing Sales Market Share by Major Countries in 2020

    • Figure Brazil Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Table South America Pharmacovigilance (PV) Outsourcing Sales by Types from 2016 to 2026

    • Table South America Pharmacovigilance (PV) Outsourcing Sales Market Share by Types from 2016 to 2026

    • Table South America Pharmacovigilance (PV) Outsourcing Value by Types from 2016 to 2026

    • Table South America Pharmacovigilance (PV) Outsourcing Value Market Share by Types from 2016 to 2026

    • Table South America Pharmacovigilance (PV) Outsourcing Sales by Application from 2016 to 2026

    • Table South America Pharmacovigilance (PV) Outsourcing Sales Market Share by Application from 2016 to 2026

    • Table South America Pharmacovigilance (PV) Outsourcing Value by Application from 2016 to 2026

    • Table South America Pharmacovigilance (PV) Outsourcing Value Market Share by Application from 2016 to 2026

    • Table Middle East Pharmacovigilance (PV) Outsourcing Revenue by Countries from 2016 to 2026

    • Table Middle East Pharmacovigilance (PV) Outsourcing Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Pharmacovigilance (PV) Outsourcing Revenue Market Share by Major Countries in 2020

    • Table Middle East Pharmacovigilance (PV) Outsourcing Sales by Countries from 2016 to 2026

    • Table Middle East Pharmacovigilance (PV) Outsourcing Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Pharmacovigilance (PV) Outsourcing Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Pharmacovigilance (PV) Outsourcing Sales by Types from 2016 to 2026

    • Table Middle East Pharmacovigilance (PV) Outsourcing Sales Market Share by Types from 2016 to 2026

    • Table Middle East Pharmacovigilance (PV) Outsourcing Value by Types from 2016 to 2026

    • Table Middle East Pharmacovigilance (PV) Outsourcing Value Market Share by Types from 2016 to 2026

    • Table Middle East Pharmacovigilance (PV) Outsourcing Sales by Application from 2016 to 2026

    • Table Middle East Pharmacovigilance (PV) Outsourcing Sales Market Share by Application from 2016 to 2026

    • Table Middle East Pharmacovigilance (PV) Outsourcing Value by Application from 2016 to 2026

    • Table Middle East Pharmacovigilance (PV) Outsourcing Value Market Share by Application from 2016 to 2026

    • Table Africa Pharmacovigilance (PV) Outsourcing Revenue by Countries from 2016 to 2026

    • Table Africa Pharmacovigilance (PV) Outsourcing Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Pharmacovigilance (PV) Outsourcing Revenue Market Share by Major Countries in 2020

    • Table Africa Pharmacovigilance (PV) Outsourcing Sales by Countries from 2016 to 2026

    • Table Africa Pharmacovigilance (PV) Outsourcing Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Pharmacovigilance (PV) Outsourcing Sales Market Share by Major Countries in 2020

    • Figure Nigeria Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Pharmacovigilance (PV) Outsourcing Sales by Types from 2016 to 2026

    • Table Africa Pharmacovigilance (PV) Outsourcing Sales Market Share by Types from 2016 to 2026

    • Table Africa Pharmacovigilance (PV) Outsourcing Value by Types from 2016 to 2026

    • Table Africa Pharmacovigilance (PV) Outsourcing Value Market Share by Types from 2016 to 2026

    • Table Africa Pharmacovigilance (PV) Outsourcing Sales by Application from 2016 to 2026

    • Table Africa Pharmacovigilance (PV) Outsourcing Sales Market Share by Application from 2016 to 2026

    • Table Africa Pharmacovigilance (PV) Outsourcing Value by Application from 2016 to 2026

    • Table Africa Pharmacovigilance (PV) Outsourcing Value Market Share by Application from 2016 to 2026

    • Table Oceania Pharmacovigilance (PV) Outsourcing Revenue by Countries from 2016 to 2026

    • Table Oceania Pharmacovigilance (PV) Outsourcing Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Pharmacovigilance (PV) Outsourcing Revenue Market Share by Major Countries in 2020

    • Table Oceania Pharmacovigilance (PV) Outsourcing Sales by Countries from 2016 to 2026

    • Table Oceania Pharmacovigilance (PV) Outsourcing Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Pharmacovigilance (PV) Outsourcing Sales Market Share by Major Countries in 2020

    • Figure Australia Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance (PV) Outsourcing Market Value and Growth Rate from 2016 to 2026

    • Figure Others Pharmacovigilance (PV) Outsourcing Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Pharmacovigilance (PV) Outsourcing Sales by Types from 2016 to 2026

    • Table Oceania Pharmacovigilance (PV) Outsourcing Sales Market Share by Types from 2016 to 2026

    • Table Oceania Pharmacovigilance (PV) Outsourcing Value by Types from 2016 to 2026

    • Table Oceania Pharmacovigilance (PV) Outsourcing Value Market Share by Types from 2016 to 2026

    • Table Oceania Pharmacovigilance (PV) Outsourcing Sales by Application from 2016 to 2026

    • Table Oceania Pharmacovigilance (PV) Outsourcing Sales Market Share by Application from 2016 to 2026

    • Table Oceania Pharmacovigilance (PV) Outsourcing Value by Application from 2016 to 2026

    • Table Oceania Pharmacovigilance (PV) Outsourcing Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Pharmacovigilance (PV) Outsourcing

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Pharmacovigilance (PV) Outsourcing with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US